SEC Filings TLDR

I-MAB reported updated safety, efficacy, and biomarker data from the Phase I monotherapy study of Givastomig, a novel Claudin 18.2/4-1BB bispecific antibody, in patients with Claudin 18.2 positive advanced gastroesophageal carcinoma (GEC). The study, which included 45 patients, showed that Givastomig was well tolerated...

Hesai Group has announced that its board of directors will hold a meeting on November 11, 2025, to consider and approve the unaudited quarterly results for the three and nine months ended September 30, 2025. The company will also host an earnings conference call on the same day at 7:00 A.M. U.S. Eastern Time (8:00 P.M....

On October 15, 2025, Ms. Amy Hsiao Ming Fong resigned from her positions as president, interim chief financial officer, and director of Helport AI Limited due to urgent family matters. Her resignation was not related to any disagreement with the company. Ms. Fong was appointed as a senior advisor to ensure a smooth tra...

Haoxi Health Technology Limited has successfully closed its private placement offering, issuing 5,217,391 Class A ordinary shares at a purchase price of $0.23 per share. The offering, which was conducted under Regulation S of the Securities Act of 1933, resulted in gross proceeds of $1.2 million before customary expens...

HSBC Holdings plc announced the conclusion of its share buy-back program, which commenced on 31 July 2025. The company repurchased a total of 136,301,568 ordinary shares on UK Venues at a volume-weighted average price of £9.8038 per share and 91,040,400 ordinary shares on the Hong Kong Stock Exchange at a volume-weight...

Harmony Gold Mining Company Limited has published its annual reporting suite for the financial year ended 30 June 2025 (FY25). The suite includes the Integrated Report, Sustainability Report, Operational Report, Financial Report, Mineral Resources and Mineral Reserves Report, Climate Action and Impact Report, and Remun...

Harmony Gold Mining Company Limited has successfully completed the acquisition of MAC Copper Limited, securing full ownership of the CSA copper mine in New South Wales, Australia. The transaction, valued at US$1.01 billion, was funded through cash reserves and a US$1.25 billion bridge facility. This acquisition marks a...

GSK plc announced that the U.S. Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy. The approval ...

GSK plc, acting through BNP Paribas SA, purchased 366,000 of its ordinary shares on 23 October 2025 as part of its existing buyback program. The shares were bought at prices ranging from 1,640.00p to 1,657.50p, with a volume-weighted average price of 1,648.10p. The purchased shares will be held as Treasury shares. Foll...

Grupo Televisa, S.A.B. reported its financial results for the third quarter of 2025. The company experienced a 4.8% decline in revenue, amounting to Ps.14,627.0 million, compared to Ps.15,362.8 million in the same period last year. Operating segment income decreased by 0.7%, resulting in a margin of 38.5%. The Cable se...

Galapagos NV announced that it will present new in vitro pharmacological data for its selective TYK2 inhibitor, GLPG3667, at the American College of Rheumatology (ACR) Convergence 2025. The data suggests differentiation from other TYK2 inhibitors at their clinical dose regimens. Key findings include inhibition of the I...

Fangdd Network Group Ltd. (Nasdaq: DUO) has entered into a convertible note purchase agreement to issue a convertible promissory note worth US$34.32 million to an investor. The note will be used to satisfy payment obligations under an asset purchase agreement dated September 29, 2025. The note matures in 364 days and i...

The provided filing content is empty or contains no information. There is no data to summarize or analyze....

Electra Battery Materials Corporation filed a Form 6-K with the SEC on October 23, 2025, reporting as a foreign private issuer. The filing includes several exhibits, such as Amendment No. 2 to the Transaction Support Agreement, an Exchange Agreement, and various other agreements related to financial transactions and re...

Embraer S.A. announced that its indirect subsidiary, Embraer Netherlands Finance B.V., has issued a notice of redemption for all outstanding principal amount of its 6.950% Notes due 2028. The redemption will take place on November 25, 2025, in accordance with the terms and conditions set forth in the Indenture dated Se...

Dynagas LNG Partners LP (NYSE: DLNG) announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its Series A Cumulative Redeemable Perpetual Preferred Units (NYSE: DLNG PR A) for the period from August 12, 2025 to November 11, 2025. The distribution is payable on November 12, 2025, to...

Draganfly Inc. announced the unveiling of its new Outrider Drone at the Cochise County Border Drone Summit, an invitation-only event taking place on November 16–17, 2025, in Sierra Vista, Arizona. The Outrider Drone is designed for long-endurance surveillance and logistics missions, integrating advanced imaging and sec...

DRDGOLD Limited reported dealings in securities and changes to the board and board committees. The company disclosed the disposal of vested DRDGOLD Shares by participants under the equity settled long-term incentive scheme (LTI Scheme). The shares were disposed of through a pooled sale arrangement facilitated by an ind...

Dr. Reddy’s Laboratories Limited, a foreign private issuer, submitted a Form 6-K to the Securities and Exchange Commission (SEC) in October 2025. The filing includes an intimation dated October 24, 2025, as an exhibit. The form indicates that the registrant files annual reports under Form 20-F and is not submitting the...

Dr. Reddy’s Laboratories Limited has announced a change in its senior management. Ms. Archana Bhaskar, the Chief Human Resources Officer (CHRO), will resign effective November 30, 2025. The Board of Directors, based on the recommendation of the Nomination, Governance and Compensation Committee, has assigned the additio...

Dr. Reddy's Laboratories announced its consolidated financial results for the quarter and six months ended September 30, 2025. The company reported revenues of ₹88,051 million for Q2 FY2026, a 9.8% year-over-year (YoY) increase, and ₹173,503 million for H1 FY2026, a 10.6% YoY increase. Gross margin for Q2 FY2026 stood ...

Dr. Reddy's Laboratories Limited reported its unaudited condensed consolidated interim financial statements for the quarter ended September 30, 2025. The company achieved a profit of $319 million, with revenues of $1.954 billion. The financial statements were prepared in accordance with International Accounting Standar...

Cosan S.A. (B3: CSAN3; NYSE: CSAN) has announced a primary offering of its common shares. The offering will initially comprise the issuance of 1,450,000,000 shares, with the possibility of increasing this number by up to 25% to meet excess demand. The shares will be offered in Brazil to the general investing public, in...

Cosan S.A. reported its financial and operational results for the six-month period ending June 30, 2025. The company's net operating revenue reached R$20.1 billion, with a gross margin of 32.1%. However, the net income for the period was a loss of R$2.5 billion, primarily due to a loss of R$2.0 billion from the equity ...

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (OMA) reported its unaudited, consolidated financial and operating results for the third quarter of 2025. Key highlights include a 7.7% increase in passenger traffic, reaching 7.6 million passengers, and a 9.8% growth in combined aeronautical and non-aeronautical rev...